For citations:
Kolbin A.S., Kurylev A.A. What is the role of antineoplastic drug safety in reimbursement decision making? FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2018;11(3):38-42. (In Russ.) https://doi.org/10.17749/2070-4909.2018.11.3-038-042

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.